Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure

Published:2007-05-11 Issue:6-7 Volume:9 Page:594-601
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Keyhan Golyar¹,Chen Shun-Fu¹,Pilote Louise¹

Affiliation:

1. Division of Clinical Epidemiology; The Research Institute of the McGill University Health Centre; 1650 Cedar Avenue, Room L10-421 Montreal QC Canada H3G 1A4

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. The expanding national burden of heart failure in the United States: the influence of heart failure in women;Koelling;Am Heart J,2004

2. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the evaluation and management of heart failure);Hunt;Circulation,2001

3. It is important to examine gender differences in the epidemiology and outcome of severe heart failure?;Jessup;J Thorac Cardiovasc Surg,2004

4. The ‘real’ women with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists;Opasich;Eur J Heart Fail,2004

5. Gender differences in patients with heart failure;Stromberg;Eur J Cardiovasc Nurs,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Sex Differences on the Treatment Effectiveness in Heart Failure with Reduced Ejection Fraction Related to Clinical Endpoints and Quality of Life;Current Heart Failure Reports;2023-12-07

2. Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review;Pharmaceutical Medicine;2023-03

3. Sex Differences in Therapies for Heart Failure;Current Pharmaceutical Design;2022-05

4. Effects of renin–angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation;European Heart Journal - Cardiovascular Pharmacotherapy;2022-04-20

5. Heart failure with preserved ejection fraction after the PARAGON-HF trial results: current knowledge and future directions;Kardiologia Polska;2020-12-23